Barbosa, M.S.; Sampaio, B.A.; Spergser, J.; Rosengarten, R.; Marques, L.M.; Chopra-Dewasthaly, R.
Mycoplasma agalactiae Vaccines: Current Status, Hurdles, and Opportunities Due to Advances in Pathogenicity Studies. Vaccines 2024, 12, 156.
https://doi.org/10.3390/vaccines12020156
AMA Style
Barbosa MS, Sampaio BA, Spergser J, Rosengarten R, Marques LM, Chopra-Dewasthaly R.
Mycoplasma agalactiae Vaccines: Current Status, Hurdles, and Opportunities Due to Advances in Pathogenicity Studies. Vaccines. 2024; 12(2):156.
https://doi.org/10.3390/vaccines12020156
Chicago/Turabian Style
Barbosa, Maysa Santos, Beatriz Almeida Sampaio, Joachim Spergser, Renate Rosengarten, Lucas Miranda Marques, and Rohini Chopra-Dewasthaly.
2024. "Mycoplasma agalactiae Vaccines: Current Status, Hurdles, and Opportunities Due to Advances in Pathogenicity Studies" Vaccines 12, no. 2: 156.
https://doi.org/10.3390/vaccines12020156
APA Style
Barbosa, M. S., Sampaio, B. A., Spergser, J., Rosengarten, R., Marques, L. M., & Chopra-Dewasthaly, R.
(2024). Mycoplasma agalactiae Vaccines: Current Status, Hurdles, and Opportunities Due to Advances in Pathogenicity Studies. Vaccines, 12(2), 156.
https://doi.org/10.3390/vaccines12020156
